VitaDAO Longevity Research Funding

AMBER Tx General

Strategy Notes

VitaDAO explicitly funds longevity/aging-as-disease research via their decentralized IP collective model. The applicant's independent research focuses on addiction neuropharmacology (CCT model), which falls outside the longevity research remit. While computational pharmacology skills transfer, the thematic mismatch is significant and unlikely to align with VitaDAO's research priorities.

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: —
Cycle: rolling
Amount: —
Type: grant
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-09 OPEN → INELIGIBLE · VitaDAO exclusively funds longevity and aging-as-disease research; the applicant's sole research focus — the CCT model for addiction/reward-memory encoding — falls entirely outside this mandate. There is no longevity angle in the existing preprints or platforms, and VitaDAO's community governance model votes on thematic fit, meaning off-topic proposals are rejected at triage.